Rare diseases
Investigational molecules
Locations
Back to Sweden745 clinical trials in Stockholm, Sweden across 8 research sites. Every trial is listed in the EU Clinical Trials Register and updated daily.
Our site in SwedenKliniska-Provningar.se(opens in a new tab)Study of INCB099280 and Ipilimumab for Patients with Advanced Solid Tumors
SwedenStudy on Hydroxychloroquine, Leflunomide, and Mycophenolate Mofetil for Patients with Primary Sjogren's Syndrome
SwedenStudy of Bemarituzumab and Chemotherapy for Patients with Advanced Stomach or Gastroesophageal Cancer with FGFR2b Overexpression
SwedenStudy on Adding Apalutamide to Radiotherapy and LHRH Agonist for High-Risk Patients with Hormone-Sensitive Prostate Cancer
SwedenStudy on the Effectiveness of Autogene Cevumeran in Patients with ctDNA Positive, Resected Stage II (High Risk) and Stage III Colorectal Cancer
SwedenStudy on MK-2870 for Patients with Endometrial Cancer After Platinum and Immunotherapy Treatment
SwedenStudy on Simvastatin for Treating Primary Sclerosing Cholangitis in Patients
SwedenStudy on Atezolizumab with Platinum-Based Chemotherapy for Patients with Early-Stage Resectable Non-Small Cell Lung Cancer
SwedenStudy on Tisagenlecleucel for High-Risk B-Cell Acute Lymphoblastic Leukemia in Pediatric and Young Adult Patients with Minimal Residual Disease
SwedenStudy of Tocilizumab Treatment for Chronic Antibody-Mediated Rejection in Kidney Transplant Recipients
SwedenStudy Comparing Sonrotoclax and Zanubrutinib with Venetoclax and Obinutuzumab for Patients with Untreated Chronic Lymphocytic Leukemia
SwedenStudy on the Effectiveness and Safety of GSK4527226 in Patients with Early Alzheimer's Disease
SwedenThe busiest research cities in the country
What the registry says about research in the country
Clinical trials focusing on metastatic prostate cancer and advanced breast cancer treatments, evaluating new therapeutic approaches and drug combinations.
Innovative research comparing various treatment protocols and investigating survival outcomes.
Studies evaluating vaccines and treatments for respiratory syncytial virus, herpes zoster, and HPV infections.
Focus on prevention and immune response in various age groups.
Research on heart failure prevention and hypertrophic cardiomyopathy, testing new therapeutic combinations.
Emphasis on improving patient outcomes and testing novel drug combinations.
Trials investigating treatments for Parkinson's disease and multiple sclerosis, focusing on disease progression and symptom management.
Studies evaluating both novel and existing therapeutic approaches.
Research on obesity and type 2 diabetes treatments, evaluating new medications for weight management.
Focus on lifestyle interventions combined with pharmaceutical approaches.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
